Acquired Activated Protein C Resistance Associated with IgG Antibodies against β2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous Thromboembolism
- 1 March 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (3), 545-552
- https://doi.org/10.1373/clinchem.2004.043414
Abstract
Background: Venous thromboembolic events such as deep vein thrombosis and pulmonary embolism are common manifestations of antiphospholipid syndrome. Our aim was to clarify the roles of anti-phospholipid (aPL) antibodies in the pathogenesis of venous thromboembolism (VTE) in patients with systemic lupus erythematosus (SLE).Keywords
This publication has 41 references indexed in Scilit:
- Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/β2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodiesThrombosis and Haemostasis, 2004
- Acquired activated protein C resistance is associated with the co-existence of anti-prothrombin antibodies and lupus anticoagulant activity in patients with systemic lupus erythematosusBritish Journal of Haematology, 2002
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationThe New England Journal of Medicine, 1999
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid antibodies and thrombosisThe Lancet, 1999
- Mechanism of action of β2-glycoprotein I-dependent lupus anticoagulantsLupus, 1998
- Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.JCI Insight, 1997
- INCREASED LEVELS OF β2 GLYCOPROTEIN-I ANTIGEN AND β2 GLYCOPROTEIN-I BINDING ANTIBODIES ARE ASSOCIATED WITH A HISTORY OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH SLE AND PRIMARY ANTIPHOSPHOLIPID SYNDROMERheumatology, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SThe New England Journal of Medicine, 1984